Abstract

Mutations of the BRAF protein serine/threonine kinase gene have recently been identified in a variety of human cancers, most notably melanomas. We sought to determine the frequency of BRAF mutations in human lung cancer pathogenesis. Analysis of BRAF sequence from 127 primary human lung adenocarcinomas revealed mutations in two tumor specimens, one in exon 11 (G465V), and a second in exon 15 (L596R). These specimens belong to the same adenocarcinoma subgroup as defined by clustering of gene expression data. BRAF may provide a target for anticancer chemotherapy in a subset of lung adenocarcinoma patients.

Keywords

ExonAdenocarcinomaMissense mutationCancer researchLung cancerGeneBiologyMutationAdenocarcinoma of the lungCancerGeneticsMedicinePathology

Affiliated Institutions

Related Publications

Publication Info

Year
2002
Type
article
Volume
62
Issue
23
Pages
7001-3
Citations
284
Access
Closed

External Links

Citation Metrics

284
OpenAlex

Cite This

Katsuhiko Naoki, Tzu Hsiu Chen, William G. Richards et al. (2002). Missense mutations of the BRAF gene in human lung adenocarcinoma.. PubMed , 62 (23) , 7001-3.